Global Medical Inhaled Nitric Oxide Market Growth 2025-2031

Product Code: 1248460

Industry: Medical Care

Published: Jul 09,2025

Pages: 81

Delivery Time: 2-3 business days

Global Medical Inhaled Nitric Oxide Market Growth 2025-2031

Product Code: 1248460

Industry: Medical Care

Published: Jul 09,2025

Pages: 81

Delivery Time: 2-3 business days

Select A Format

Single User License

USD3660

Multi Users License

USD5490

Corporate Users License

USD7320

Buy Now

Add To Cart

Or More Options：

PDF Download

Sample Request

Custom Request

Provide market analysis and obtain sources of data reports

Description

The global Medical Inhaled Nitric Oxide market size is predicted to grow from US$ 645 million in 2025 to US$ 926 million in 2031; it is expected to grow at a CAGR of 6.2% from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

Inhaled Nitric Oxide (iNO) therapy is a medical treatment involving the inhalation of nitric oxide gas, primarily used to treat conditions such as Acute Respiratory Distress Syndrome (ARDS), pulmonary hypertension, and neonatal pulmonary hypertension. As a gas-based therapy, iNO works by relaxing the smooth muscles of the pulmonary blood vessels, reducing pulmonary vascular resistance, and thereby improving oxygenation and reducing the load on the lungs and heart. iNO is most commonly used in intensive care units (ICUs), particularly for critically ill neonates and adults. Compared to traditional pharmacological treatments, iNO offers a more precise way to regulate blood flow and oxygen supply to the lungs, with fewer side effects. The therapy is delivered through specialized devices, such as inhaled nitric oxide therapy systems, portable inhalation devices, and other apparatus designed to deliver controlled amounts of nitric oxide directly to patients. These devices typically include real-time monitoring of nitric oxide concentration, oxygen levels, and gas flow rates, ensuring precise and safe treatment.

The product range for medical inhaled nitric oxide includes large ICU systems, portable systems, and home-care systems. With advancements in technology, there is an increasing demand for more efficient and user-friendly devices, especially in home-care settings. Portable nitric oxide therapy systems have become particularly important for neonates and adults with chronic conditions, offering both acute and long-term therapeutic benefits. As such, iNO therapy plays an essential role not only in emergency care but also in ongoing treatment for patients with complex respiratory issues.

The medical inhaled nitric oxide (iNO) market is experiencing rapid growth, driven by multiple factors. First, the rising incidence of chronic respiratory diseases and Acute Respiratory Distress Syndrome (ARDS) has significantly increased the demand for iNO therapy. With the aging global population and the high prevalence of lung and cardiovascular diseases, iNO has become an essential treatment option. Particularly in neonatal intensive care, iNO is widely used to treat conditions such as neonatal pulmonary hypertension. Second, with advancements in medical technology, iNO devices are becoming more compact and portable, increasing the accessibility of iNO therapy outside of hospital settings. This shift has opened up vast opportunities for home care and telemedicine solutions, expanding the market.

However, there are risks and challenges in the market. First, the high cost of iNO therapy equipment presents a significant barrier, particularly for healthcare institutions in developing countries. Second, the use of iNO requires specialized equipment and expertise, leading to a need for extensive training for healthcare providers. Furthermore, prolonged use of iNO may lead to potential side effects, such as damage to the lungs or other organs due to high concentrations of nitrogen oxides, necessitating strict monitoring during therapy. The market is also highly concentrated, with a few major players dominating, which could potentially lead to market imbalances in terms of competition.

With ongoing advancements in technology, the performance and reliability of iNO devices continue to improve. Emerging technological trends include more precise gas delivery systems, integrated smart monitoring features, and the development of user-friendly home therapy systems. In the future, the integration of artificial intelligence and big data into iNO therapy could lead to more personalized and intelligent treatment solutions, marking a new direction in the market's evolution.

LP Information, Inc. (LPI) ' newest research report, the “Medical Inhaled Nitric Oxide Industry Forecast” looks at past sales and reviews total world Medical Inhaled Nitric Oxide sales in 2024, providing a comprehensive analysis by region and market sector of projected Medical Inhaled Nitric Oxide sales for 2025 through 2031. With Medical Inhaled Nitric Oxide sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Medical Inhaled Nitric Oxide industry.

This Insight Report provides a comprehensive analysis of the global Medical Inhaled Nitric Oxide landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Medical Inhaled Nitric Oxide portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Medical Inhaled Nitric Oxide market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Medical Inhaled Nitric Oxide and breaks down the forecast by NO Concentration, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Medical Inhaled Nitric Oxide.

This report presents a comprehensive overview, market shares, and growth opportunities of Medical Inhaled Nitric Oxide market by product type, application, key manufacturers and key regions and countries.

Segmentation by NO Concentration:
    High Purity iNO
    Standard Purity iNO

Segmentation by Application:
    Infants PPHN
    ARDS, etc.

This report also splits the market by region:
    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

    Mallinckrodt (INOmax)
    Linde (Noxivent)
    Air Liquide (KINOX)

Key Questions Addressed in this Report
What is the 10-year outlook for the global Medical Inhaled Nitric Oxide market?
What factors are driving Medical Inhaled Nitric Oxide market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Medical Inhaled Nitric Oxide market opportunities vary by end market size?
How does Medical Inhaled Nitric Oxide break out by NO Concentration, by Application?

Table Of Contents

1 Scope of the Report
    1.1 Market Introduction
    1.2 Years Considered
    1.3 Research Objectives
    1.4 Market Research Methodology
    1.5 Research Process and Data Source
    1.6 Economic Indicators
    1.7 Currency Considered
    1.8 Market Estimation Caveats

2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global Medical Inhaled Nitric Oxide Annual Sales 2020-2031
        2.1.2 World Current & Future Analysis for Medical Inhaled Nitric Oxide by Geographic Region, 2020, 2024 & 2031
        2.1.3 World Current & Future Analysis for Medical Inhaled Nitric Oxide by Country/Region, 2020, 2024 & 2031
    2.2 Medical Inhaled Nitric Oxide Segment by NO Concentration
        2.2.1 High Purity iNO
        2.2.2 Standard Purity iNO
    2.3 Medical Inhaled Nitric Oxide Sales by NO Concentration
        2.3.1 Global Medical Inhaled Nitric Oxide Sales Market Share by NO Concentration (2020-2025)
        2.3.2 Global Medical Inhaled Nitric Oxide Revenue and Market Share by NO Concentration (2020-2025)
        2.3.3 Global Medical Inhaled Nitric Oxide Sale Price by NO Concentration (2020-2025)
    2.4 Medical Inhaled Nitric Oxide Segment by Application
        2.4.1 Infants PPHN
        2.4.2 ARDS, etc.
    2.5 Medical Inhaled Nitric Oxide Sales by Application
        2.5.1 Global Medical Inhaled Nitric Oxide Sale Market Share by Application (2020-2025)
        2.5.2 Global Medical Inhaled Nitric Oxide Revenue and Market Share by Application (2020-2025)
        2.5.3 Global Medical Inhaled Nitric Oxide Sale Price by Application (2020-2025)

3 Global by Company
    3.1 Global Medical Inhaled Nitric Oxide Breakdown Data by Company
        3.1.1 Global Medical Inhaled Nitric Oxide Annual Sales by Company (2020-2025)
        3.1.2 Global Medical Inhaled Nitric Oxide Sales Market Share by Company (2020-2025)
    3.2 Global Medical Inhaled Nitric Oxide Annual Revenue by Company (2020-2025)
        3.2.1 Global Medical Inhaled Nitric Oxide Revenue by Company (2020-2025)
        3.2.2 Global Medical Inhaled Nitric Oxide Revenue Market Share by Company (2020-2025)
    3.3 Global Medical Inhaled Nitric Oxide Sale Price by Company
    3.4 Key Manufacturers Medical Inhaled Nitric Oxide Producing Area Distribution, Sales Area, Product Type
        3.4.1 Key Manufacturers Medical Inhaled Nitric Oxide Product Location Distribution
        3.4.2 Players Medical Inhaled Nitric Oxide Products Offered
    3.5 Market Concentration Rate Analysis
        3.5.1 Competition Landscape Analysis
        3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
    3.6 New Products and Potential Entrants
    3.7 Market M&A Activity & Strategy

4 World Historic Review for Medical Inhaled Nitric Oxide by Geographic Region
    4.1 World Historic Medical Inhaled Nitric Oxide Market Size by Geographic Region (2020-2025)
        4.1.1 Global Medical Inhaled Nitric Oxide Annual Sales by Geographic Region (2020-2025)
        4.1.2 Global Medical Inhaled Nitric Oxide Annual Revenue by Geographic Region (2020-2025)
    4.2 World Historic Medical Inhaled Nitric Oxide Market Size by Country/Region (2020-2025)
        4.2.1 Global Medical Inhaled Nitric Oxide Annual Sales by Country/Region (2020-2025)
        4.2.2 Global Medical Inhaled Nitric Oxide Annual Revenue by Country/Region (2020-2025)
    4.3 Americas Medical Inhaled Nitric Oxide Sales Growth
    4.4 APAC Medical Inhaled Nitric Oxide Sales Growth
    4.5 Europe Medical Inhaled Nitric Oxide Sales Growth
    4.6 Middle East & Africa Medical Inhaled Nitric Oxide Sales Growth

5 Americas
    5.1 Americas Medical Inhaled Nitric Oxide Sales by Country
        5.1.1 Americas Medical Inhaled Nitric Oxide Sales by Country (2020-2025)
        5.1.2 Americas Medical Inhaled Nitric Oxide Revenue by Country (2020-2025)
    5.2 Americas Medical Inhaled Nitric Oxide Sales by NO Concentration (2020-2025)
    5.3 Americas Medical Inhaled Nitric Oxide Sales by Application (2020-2025)
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil

6 APAC
    6.1 APAC Medical Inhaled Nitric Oxide Sales by Region
        6.1.1 APAC Medical Inhaled Nitric Oxide Sales by Region (2020-2025)
        6.1.2 APAC Medical Inhaled Nitric Oxide Revenue by Region (2020-2025)
    6.2 APAC Medical Inhaled Nitric Oxide Sales by NO Concentration (2020-2025)
    6.3 APAC Medical Inhaled Nitric Oxide Sales by Application (2020-2025)
    6.4 China
    6.5 Japan
    6.6 South Korea
    6.7 Southeast Asia
    6.8 India
    6.9 Australia
    6.10 China Taiwan

7 Europe
    7.1 Europe Medical Inhaled Nitric Oxide by Country
        7.1.1 Europe Medical Inhaled Nitric Oxide Sales by Country (2020-2025)
        7.1.2 Europe Medical Inhaled Nitric Oxide Revenue by Country (2020-2025)
    7.2 Europe Medical Inhaled Nitric Oxide Sales by NO Concentration (2020-2025)
    7.3 Europe Medical Inhaled Nitric Oxide Sales by Application (2020-2025)
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia

8 Middle East & Africa
    8.1 Middle East & Africa Medical Inhaled Nitric Oxide by Country
        8.1.1 Middle East & Africa Medical Inhaled Nitric Oxide Sales by Country (2020-2025)
        8.1.2 Middle East & Africa Medical Inhaled Nitric Oxide Revenue by Country (2020-2025)
    8.2 Middle East & Africa Medical Inhaled Nitric Oxide Sales by NO Concentration (2020-2025)
    8.3 Middle East & Africa Medical Inhaled Nitric Oxide Sales by Application (2020-2025)
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries

9 Market Drivers, Challenges and Trends
    9.1 Market Drivers & Growth Opportunities
    9.2 Market Challenges & Risks
    9.3 Industry Trends

10 Manufacturing Cost Structure Analysis
    10.1 Raw Material and Suppliers
    10.2 Manufacturing Cost Structure Analysis of Medical Inhaled Nitric Oxide
    10.3 Manufacturing Process Analysis of Medical Inhaled Nitric Oxide
    10.4 Industry Chain Structure of Medical Inhaled Nitric Oxide

11 Marketing, Distributors and Customer
    11.1 Sales Channel
        11.1.1 Direct Channels
        11.1.2 Indirect Channels
    11.2 Medical Inhaled Nitric Oxide Distributors
    11.3 Medical Inhaled Nitric Oxide Customer

12 World Forecast Review for Medical Inhaled Nitric Oxide by Geographic Region
    12.1 Global Medical Inhaled Nitric Oxide Market Size Forecast by Region
        12.1.1 Global Medical Inhaled Nitric Oxide Forecast by Region (2026-2031)
        12.1.2 Global Medical Inhaled Nitric Oxide Annual Revenue Forecast by Region (2026-2031)
    12.2 Americas Forecast by Country (2026-2031)
    12.3 APAC Forecast by Region (2026-2031)
    12.4 Europe Forecast by Country (2026-2031)
    12.5 Middle East & Africa Forecast by Country (2026-2031)
    12.6 Global Medical Inhaled Nitric Oxide Forecast by NO Concentration (2026-2031)
    12.7 Global Medical Inhaled Nitric Oxide Forecast by Application (2026-2031)

13 Key Players Analysis
    13.1 Mallinckrodt (INOmax)
        13.1.1 Mallinckrodt (INOmax) Company Information
        13.1.2 Mallinckrodt (INOmax) Medical Inhaled Nitric Oxide Product Portfolios and Specifications
        13.1.3 Mallinckrodt (INOmax) Medical Inhaled Nitric Oxide Sales, Revenue, Price and Gross Margin (2020-2025)
        13.1.4 Mallinckrodt (INOmax) Main Business Overview
        13.1.5 Mallinckrodt (INOmax) Latest Developments
    13.2 Linde (Noxivent)
        13.2.1 Linde (Noxivent) Company Information
        13.2.2 Linde (Noxivent) Medical Inhaled Nitric Oxide Product Portfolios and Specifications
        13.2.3 Linde (Noxivent) Medical Inhaled Nitric Oxide Sales, Revenue, Price and Gross Margin (2020-2025)
        13.2.4 Linde (Noxivent) Main Business Overview
        13.2.5 Linde (Noxivent) Latest Developments
    13.3 Air Liquide (KINOX)
        13.3.1 Air Liquide (KINOX) Company Information
        13.3.2 Air Liquide (KINOX) Medical Inhaled Nitric Oxide Product Portfolios and Specifications
        13.3.3 Air Liquide (KINOX) Medical Inhaled Nitric Oxide Sales, Revenue, Price and Gross Margin (2020-2025)
        13.3.4 Air Liquide (KINOX) Main Business Overview
        13.3.5 Air Liquide (KINOX) Latest Developments

14 Research Findings and Conclusion

List Of Tables

List of Tables
 Table 1. Medical Inhaled Nitric Oxide Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
 Table 2. Medical Inhaled Nitric Oxide Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
 Table 3. Major Players of High Purity iNO
 Table 4. Major Players of Standard Purity iNO
 Table 5. Global Medical Inhaled Nitric Oxide Sales by NO Concentration (2020-2025) & (Million L)
 Table 6. Global Medical Inhaled Nitric Oxide Sales Market Share by NO Concentration (2020-2025)
 Table 7. Global Medical Inhaled Nitric Oxide Revenue by NO Concentration (2020-2025) & ($ million)
 Table 8. Global Medical Inhaled Nitric Oxide Revenue Market Share by NO Concentration (2020-2025)
 Table 9. Global Medical Inhaled Nitric Oxide Sale Price by NO Concentration (2020-2025) & (USD/L)
 Table 10. Global Medical Inhaled Nitric Oxide Sale by Application (2020-2025) & (Million L)
 Table 11. Global Medical Inhaled Nitric Oxide Sale Market Share by Application (2020-2025)
 Table 12. Global Medical Inhaled Nitric Oxide Revenue by Application (2020-2025) & ($ million)
 Table 13. Global Medical Inhaled Nitric Oxide Revenue Market Share by Application (2020-2025)
 Table 14. Global Medical Inhaled Nitric Oxide Sale Price by Application (2020-2025) & (USD/L)
 Table 15. Global Medical Inhaled Nitric Oxide Sales by Company (2020-2025) & (Million L)
 Table 16. Global Medical Inhaled Nitric Oxide Sales Market Share by Company (2020-2025)
 Table 17. Global Medical Inhaled Nitric Oxide Revenue by Company (2020-2025) & ($ millions)
 Table 18. Global Medical Inhaled Nitric Oxide Revenue Market Share by Company (2020-2025)
 Table 19. Global Medical Inhaled Nitric Oxide Sale Price by Company (2020-2025) & (USD/L)
 Table 20. Key Manufacturers Medical Inhaled Nitric Oxide Producing Area Distribution and Sales Area
 Table 21. Players Medical Inhaled Nitric Oxide Products Offered
 Table 22. Medical Inhaled Nitric Oxide Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
 Table 23. New Products and Potential Entrants
 Table 24. Market M&A Activity & Strategy
 Table 25. Global Medical Inhaled Nitric Oxide Sales by Geographic Region (2020-2025) & (Million L)
 Table 26. Global Medical Inhaled Nitric Oxide Sales Market Share Geographic Region (2020-2025)
 Table 27. Global Medical Inhaled Nitric Oxide Revenue by Geographic Region (2020-2025) & ($ millions)
 Table 28. Global Medical Inhaled Nitric Oxide Revenue Market Share by Geographic Region (2020-2025)
 Table 29. Global Medical Inhaled Nitric Oxide Sales by Country/Region (2020-2025) & (Million L)
 Table 30. Global Medical Inhaled Nitric Oxide Sales Market Share by Country/Region (2020-2025)
 Table 31. Global Medical Inhaled Nitric Oxide Revenue by Country/Region (2020-2025) & ($ millions)
 Table 32. Global Medical Inhaled Nitric Oxide Revenue Market Share by Country/Region (2020-2025)
 Table 33. Americas Medical Inhaled Nitric Oxide Sales by Country (2020-2025) & (Million L)
 Table 34. Americas Medical Inhaled Nitric Oxide Sales Market Share by Country (2020-2025)
 Table 35. Americas Medical Inhaled Nitric Oxide Revenue by Country (2020-2025) & ($ millions)
 Table 36. Americas Medical Inhaled Nitric Oxide Sales by NO Concentration (2020-2025) & (Million L)
 Table 37. Americas Medical Inhaled Nitric Oxide Sales by Application (2020-2025) & (Million L)
 Table 38. APAC Medical Inhaled Nitric Oxide Sales by Region (2020-2025) & (Million L)
 Table 39. APAC Medical Inhaled Nitric Oxide Sales Market Share by Region (2020-2025)
 Table 40. APAC Medical Inhaled Nitric Oxide Revenue by Region (2020-2025) & ($ millions)
 Table 41. APAC Medical Inhaled Nitric Oxide Sales by NO Concentration (2020-2025) & (Million L)
 Table 42. APAC Medical Inhaled Nitric Oxide Sales by Application (2020-2025) & (Million L)
 Table 43. Europe Medical Inhaled Nitric Oxide Sales by Country (2020-2025) & (Million L)
 Table 44. Europe Medical Inhaled Nitric Oxide Revenue by Country (2020-2025) & ($ millions)
 Table 45. Europe Medical Inhaled Nitric Oxide Sales by NO Concentration (2020-2025) & (Million L)
 Table 46. Europe Medical Inhaled Nitric Oxide Sales by Application (2020-2025) & (Million L)
 Table 47. Middle East & Africa Medical Inhaled Nitric Oxide Sales by Country (2020-2025) & (Million L)
 Table 48. Middle East & Africa Medical Inhaled Nitric Oxide Revenue Market Share by Country (2020-2025)
 Table 49. Middle East & Africa Medical Inhaled Nitric Oxide Sales by NO Concentration (2020-2025) & (Million L)
 Table 50. Middle East & Africa Medical Inhaled Nitric Oxide Sales by Application (2020-2025) & (Million L)
 Table 51. Key Market Drivers & Growth Opportunities of Medical Inhaled Nitric Oxide
 Table 52. Key Market Challenges & Risks of Medical Inhaled Nitric Oxide
 Table 53. Key Industry Trends of Medical Inhaled Nitric Oxide
 Table 54. Medical Inhaled Nitric Oxide Raw Material
 Table 55. Key Suppliers of Raw Materials
 Table 56. Medical Inhaled Nitric Oxide Distributors List
 Table 57. Medical Inhaled Nitric Oxide Customer List
 Table 58. Global Medical Inhaled Nitric Oxide Sales Forecast by Region (2026-2031) & (Million L)
 Table 59. Global Medical Inhaled Nitric Oxide Revenue Forecast by Region (2026-2031) & ($ millions)
 Table 60. Americas Medical Inhaled Nitric Oxide Sales Forecast by Country (2026-2031) & (Million L)
 Table 61. Americas Medical Inhaled Nitric Oxide Annual Revenue Forecast by Country (2026-2031) & ($ millions)
 Table 62. APAC Medical Inhaled Nitric Oxide Sales Forecast by Region (2026-2031) & (Million L)
 Table 63. APAC Medical Inhaled Nitric Oxide Annual Revenue Forecast by Region (2026-2031) & ($ millions)
 Table 64. Europe Medical Inhaled Nitric Oxide Sales Forecast by Country (2026-2031) & (Million L)
 Table 65. Europe Medical Inhaled Nitric Oxide Revenue Forecast by Country (2026-2031) & ($ millions)
 Table 66. Middle East & Africa Medical Inhaled Nitric Oxide Sales Forecast by Country (2026-2031) & (Million L)
 Table 67. Middle East & Africa Medical Inhaled Nitric Oxide Revenue Forecast by Country (2026-2031) & ($ millions)
 Table 68. Global Medical Inhaled Nitric Oxide Sales Forecast by NO Concentration (2026-2031) & (Million L)
 Table 69. Global Medical Inhaled Nitric Oxide Revenue Forecast by NO Concentration (2026-2031) & ($ millions)
 Table 70. Global Medical Inhaled Nitric Oxide Sales Forecast by Application (2026-2031) & (Million L)
 Table 71. Global Medical Inhaled Nitric Oxide Revenue Forecast by Application (2026-2031) & ($ millions)
 Table 72. Mallinckrodt (INOmax) Basic Information, Medical Inhaled Nitric Oxide Manufacturing Base, Sales Area and Its Competitors
 Table 73. Mallinckrodt (INOmax) Medical Inhaled Nitric Oxide Product Portfolios and Specifications
 Table 74. Mallinckrodt (INOmax) Medical Inhaled Nitric Oxide Sales (Million L), Revenue ($ Million), Price (USD/L) and Gross Margin (2020-2025)
 Table 75. Mallinckrodt (INOmax) Main Business
 Table 76. Mallinckrodt (INOmax) Latest Developments
 Table 77. Linde (Noxivent) Basic Information, Medical Inhaled Nitric Oxide Manufacturing Base, Sales Area and Its Competitors
 Table 78. Linde (Noxivent) Medical Inhaled Nitric Oxide Product Portfolios and Specifications
 Table 79. Linde (Noxivent) Medical Inhaled Nitric Oxide Sales (Million L), Revenue ($ Million), Price (USD/L) and Gross Margin (2020-2025)
 Table 80. Linde (Noxivent) Main Business
 Table 81. Linde (Noxivent) Latest Developments
 Table 82. Air Liquide (KINOX) Basic Information, Medical Inhaled Nitric Oxide Manufacturing Base, Sales Area and Its Competitors
 Table 83. Air Liquide (KINOX) Medical Inhaled Nitric Oxide Product Portfolios and Specifications
 Table 84. Air Liquide (KINOX) Medical Inhaled Nitric Oxide Sales (Million L), Revenue ($ Million), Price (USD/L) and Gross Margin (2020-2025)
 Table 85. Air Liquide (KINOX) Main Business
 Table 86. Air Liquide (KINOX) Latest Developments


List of Figures
 Figure 1. Picture of Medical Inhaled Nitric Oxide
 Figure 2. Medical Inhaled Nitric Oxide Report Years Considered
 Figure 3. Research Objectives
 Figure 4. Research Methodology
 Figure 5. Research Process and Data Source
 Figure 6. Global Medical Inhaled Nitric Oxide Sales Growth Rate 2020-2031 (Million L)
 Figure 7. Global Medical Inhaled Nitric Oxide Revenue Growth Rate 2020-2031 ($ millions)
 Figure 8. Medical Inhaled Nitric Oxide Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
 Figure 9. Medical Inhaled Nitric Oxide Sales Market Share by Country/Region (2024)
 Figure 10. Medical Inhaled Nitric Oxide Sales Market Share by Country/Region (2020, 2024 & 2031)
 Figure 11. Product Picture of High Purity iNO
 Figure 12. Product Picture of Standard Purity iNO
 Figure 13. Global Medical Inhaled Nitric Oxide Sales Market Share by NO Concentration in 2025
 Figure 14. Global Medical Inhaled Nitric Oxide Revenue Market Share by NO Concentration (2020-2025)
 Figure 15. Medical Inhaled Nitric Oxide Consumed in Infants PPHN
 Figure 16. Global Medical Inhaled Nitric Oxide Market: Infants PPHN (2020-2025) & (Million L)
 Figure 17. Medical Inhaled Nitric Oxide Consumed in ARDS, etc.
 Figure 18. Global Medical Inhaled Nitric Oxide Market: ARDS, etc. (2020-2025) & (Million L)
 Figure 19. Global Medical Inhaled Nitric Oxide Sale Market Share by Application (2024)
 Figure 20. Global Medical Inhaled Nitric Oxide Revenue Market Share by Application in 2025
 Figure 21. Medical Inhaled Nitric Oxide Sales by Company in 2025 (Million L)
 Figure 22. Global Medical Inhaled Nitric Oxide Sales Market Share by Company in 2025
 Figure 23. Medical Inhaled Nitric Oxide Revenue by Company in 2025 ($ millions)
 Figure 24. Global Medical Inhaled Nitric Oxide Revenue Market Share by Company in 2025
 Figure 25. Global Medical Inhaled Nitric Oxide Sales Market Share by Geographic Region (2020-2025)
 Figure 26. Global Medical Inhaled Nitric Oxide Revenue Market Share by Geographic Region in 2025
 Figure 27. Americas Medical Inhaled Nitric Oxide Sales 2020-2025 (Million L)
 Figure 28. Americas Medical Inhaled Nitric Oxide Revenue 2020-2025 ($ millions)
 Figure 29. APAC Medical Inhaled Nitric Oxide Sales 2020-2025 (Million L)
 Figure 30. APAC Medical Inhaled Nitric Oxide Revenue 2020-2025 ($ millions)
 Figure 31. Europe Medical Inhaled Nitric Oxide Sales 2020-2025 (Million L)
 Figure 32. Europe Medical Inhaled Nitric Oxide Revenue 2020-2025 ($ millions)
 Figure 33. Middle East & Africa Medical Inhaled Nitric Oxide Sales 2020-2025 (Million L)
 Figure 34. Middle East & Africa Medical Inhaled Nitric Oxide Revenue 2020-2025 ($ millions)
 Figure 35. Americas Medical Inhaled Nitric Oxide Sales Market Share by Country in 2025
 Figure 36. Americas Medical Inhaled Nitric Oxide Revenue Market Share by Country (2020-2025)
 Figure 37. Americas Medical Inhaled Nitric Oxide Sales Market Share by NO Concentration (2020-2025)
 Figure 38. Americas Medical Inhaled Nitric Oxide Sales Market Share by Application (2020-2025)
 Figure 39. United States Medical Inhaled Nitric Oxide Revenue Growth 2020-2025 ($ millions)
 Figure 40. Canada Medical Inhaled Nitric Oxide Revenue Growth 2020-2025 ($ millions)
 Figure 41. Mexico Medical Inhaled Nitric Oxide Revenue Growth 2020-2025 ($ millions)
 Figure 42. Brazil Medical Inhaled Nitric Oxide Revenue Growth 2020-2025 ($ millions)
 Figure 43. APAC Medical Inhaled Nitric Oxide Sales Market Share by Region in 2025
 Figure 44. APAC Medical Inhaled Nitric Oxide Revenue Market Share by Region (2020-2025)
 Figure 45. APAC Medical Inhaled Nitric Oxide Sales Market Share by NO Concentration (2020-2025)
 Figure 46. APAC Medical Inhaled Nitric Oxide Sales Market Share by Application (2020-2025)
 Figure 47. China Medical Inhaled Nitric Oxide Revenue Growth 2020-2025 ($ millions)
 Figure 48. Japan Medical Inhaled Nitric Oxide Revenue Growth 2020-2025 ($ millions)
 Figure 49. South Korea Medical Inhaled Nitric Oxide Revenue Growth 2020-2025 ($ millions)
 Figure 50. Southeast Asia Medical Inhaled Nitric Oxide Revenue Growth 2020-2025 ($ millions)
 Figure 51. India Medical Inhaled Nitric Oxide Revenue Growth 2020-2025 ($ millions)
 Figure 52. Australia Medical Inhaled Nitric Oxide Revenue Growth 2020-2025 ($ millions)
 Figure 53. China Taiwan Medical Inhaled Nitric Oxide Revenue Growth 2020-2025 ($ millions)
 Figure 54. Europe Medical Inhaled Nitric Oxide Sales Market Share by Country in 2025
 Figure 55. Europe Medical Inhaled Nitric Oxide Revenue Market Share by Country (2020-2025)
 Figure 56. Europe Medical Inhaled Nitric Oxide Sales Market Share by NO Concentration (2020-2025)
 Figure 57. Europe Medical Inhaled Nitric Oxide Sales Market Share by Application (2020-2025)
 Figure 58. Germany Medical Inhaled Nitric Oxide Revenue Growth 2020-2025 ($ millions)
 Figure 59. France Medical Inhaled Nitric Oxide Revenue Growth 2020-2025 ($ millions)
 Figure 60. UK Medical Inhaled Nitric Oxide Revenue Growth 2020-2025 ($ millions)
 Figure 61. Italy Medical Inhaled Nitric Oxide Revenue Growth 2020-2025 ($ millions)
 Figure 62. Russia Medical Inhaled Nitric Oxide Revenue Growth 2020-2025 ($ millions)
 Figure 63. Middle East & Africa Medical Inhaled Nitric Oxide Sales Market Share by Country (2020-2025)
 Figure 64. Middle East & Africa Medical Inhaled Nitric Oxide Sales Market Share by NO Concentration (2020-2025)
 Figure 65. Middle East & Africa Medical Inhaled Nitric Oxide Sales Market Share by Application (2020-2025)
 Figure 66. Egypt Medical Inhaled Nitric Oxide Revenue Growth 2020-2025 ($ millions)
 Figure 67. South Africa Medical Inhaled Nitric Oxide Revenue Growth 2020-2025 ($ millions)
 Figure 68. Israel Medical Inhaled Nitric Oxide Revenue Growth 2020-2025 ($ millions)
 Figure 69. Turkey Medical Inhaled Nitric Oxide Revenue Growth 2020-2025 ($ millions)
 Figure 70. GCC Countries Medical Inhaled Nitric Oxide Revenue Growth 2020-2025 ($ millions)
 Figure 71. Manufacturing Cost Structure Analysis of Medical Inhaled Nitric Oxide in 2025
 Figure 72. Manufacturing Process Analysis of Medical Inhaled Nitric Oxide
 Figure 73. Industry Chain Structure of Medical Inhaled Nitric Oxide
 Figure 74. Channels of Distribution
 Figure 75. Global Medical Inhaled Nitric Oxide Sales Market Forecast by Region (2026-2031)
 Figure 76. Global Medical Inhaled Nitric Oxide Revenue Market Share Forecast by Region (2026-2031)
 Figure 77. Global Medical Inhaled Nitric Oxide Sales Market Share Forecast by NO Concentration (2026-2031)
 Figure 78. Global Medical Inhaled Nitric Oxide Revenue Market Share Forecast by NO Concentration (2026-2031)
 Figure 79. Global Medical Inhaled Nitric Oxide Sales Market Share Forecast by Application (2026-2031)
 Figure 80. Global Medical Inhaled Nitric Oxide Revenue Market Share Forecast by Application (2026-2031)

Companies Mentioned

Mallinckrodt (INOmax)

Linde (Noxivent)

Air Liquide (KINOX)

Methodology

LP Information presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

Data Sourse

Primary Source

Secondary Source

Players/Suppliers

Journals and Periodicals

Industry Experts

Government Bodies

Distributors/Traders

Annual Reports

Opinion Leaders

Presentations

Front-line Staff